John Dessouki joined Metabolics as Chief Financial Officer in 2024, bringing a wealth of experience from his diverse career in finance, venture capital, and investments. Prior to Metabolics, John worked at Scientia Ventures, where he focused on investments in biotech and digital health companies. His expertise also includes key roles at Route 66 Ventures, where he helped launch the firm’s early-stage FinTech venture fund and credit opportunity fund, driving significant growth in financial services investments.

Earlier in his career, John was part of JMP Securities, where he covered internet stocks, and Hovde Capital, where he specialized in private equity investments in financial services. He began his financial career at Standard & Poor’s in structured finance, advising investment banks and hedge funds on complex credit transactions.

John holds an MBA from the Darden School of Business at the University of Virginia and a Masters in Accounting from the College of William and Mary. He passed the Virginia State CPA Exam in 2006.